Company page

Shanghai Henlius Biotech, Inc. Class H

Shanghai Henlius Biotech, Inc. Class H, trading under the ticker 2696 on the Hong Kong market, has a market capitalization of approximately HKD 4.38 billion. The company focuses on the development and commercialization of innovative biopharmaceuticals. Its commitment to advancing healthcare solutions positions it as a notable player in the biotech industry.